{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-013132","form_type":"8-K","ticker":"PCSA","cik":"0001533743","company_name":"Processa Pharmaceuticals, Inc.","filed_at":"2024-04-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.874326+00:00","generated_at":"2026-06-04T02:18:02.285345+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"low","headline":"Processa CEO presents at MedInvest conference; no specific material data in filing","bullets":["CEO George Ng presented at MedInvest Biotech + Pharma Investor Conference on April 3, 2024 in NYC.","Presentation titled 'Next Generation Chemotherapy: Improved Treatment for More Patients' was at 10:55 AM ET.","President R&D David Young attended the meeting virtually.","Presentation furnished as Exhibit 99.1 but not included in this filing; no numbers or clinical data disclosed.","Company directs investors to website for presentation and routine disclosure."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-013132","json":"https://secwatch.observer/filing/0001493152-24-013132.json","markdown":"https://secwatch.observer/filing/0001493152-24-013132.md","text":"https://secwatch.observer/filing/0001493152-24-013132.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533743/000149315224013132/0001493152-24-013132-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533743/000149315224013132/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T02:18:02.285345+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}